TEL AVIV SOURASKY MEDICAL CENTER
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 1961-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.tasmc.org.il
Early Beta Blocker Administration in STEMI Patients With SCAI B Status
Not Applicable
Not yet recruiting
- Conditions
- ST Segment Elevation Myocardial Infarction (STEMI)Cardiogenic Shock Post Myocardial Infarction
- Interventions
- Drug: Plcacebo
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT06967194
Evaluation of Fentanyl Transdermal Patch Absorption in Hemodynamically Unstable ICU Patients.
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT06966869
- Locations
- 🇮🇱
Tel Aviv Medical Center, Tel Aviv, Israel
Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
Recruiting
- Conditions
- MyelomaLymphomaCLLMyelodysplastic SyndromeLeukemia Acute Myeloid - AML
- First Posted Date
- 2025-04-25
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 250
- Registration Number
- NCT06944119
- Locations
- 🇮🇱
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Emotional Release After Trigger Point Needling to Treat Myofascial Pain of the Head and Neck - Prospective Study
- Conditions
- Temporomandibular Disorders (TMD)Temporomandibular Dysfunction (TMD)Temporomandibular Joint and Muscle Disorder
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT06912438
- Locations
- 🇮🇱
Oral Medicine Unite, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Multiple Myeloma is a Hematologic Malignancy Characterized by the Accumulation of Malignant Plasma Cells in the Bone Marrow. Despite Advances in Treatment, Many Patients Experience Disease Relapse. Bispecific Antibodies Offer an Innovative Therapeutic Approach, But Approximately 30%-40% of Patients
Not yet recruiting
- Conditions
- Multiple Myeloma (MM)
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT06888856
Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression
Phase 2
Not yet recruiting
- Conditions
- Ovarian CancerOvarian Cancer Metastatic Recurrent
- Interventions
- Drug: Propranolol (Beta-Blocker) and Etodolac (COX-2 Inhibitor)Drug: Placebo (Matching for Propranolol & Etodolac)
- First Posted Date
- 2025-02-21
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT06839144
- Locations
- 🇮🇱
The Chaim Sheba Medical Center, Ramat Gan, Israel
🇮🇱Tel Aviv Sourasky Medical Center (Ichilov Hospital), Tel Aviv, Israel
Tailored One Anastomosis Gastric Bypass
Not Applicable
Recruiting
- Conditions
- Metabolic and Bariatric Surgery
- First Posted Date
- 2025-02-17
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT06829381
- Locations
- 🇮🇱
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
The Effect of a Mediterranean Diet on Quality of Life in Multiple Sclerosis Patients
Not Applicable
Recruiting
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 140
- Registration Number
- NCT06764563
- Locations
- 🇮🇱
Tel Aviv Sourasky medical center, Tel aviv, Israel
Does Pre-injection Local Anesthesia Affect Experienced Pain During Intra-articular Hip Injections.
Completed
- Conditions
- PainInjectionPreventionAssessment
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT06760559
- Locations
- 🇮🇱
Tel Aviv Medical Center, Tel Aviv, Israel
Changes in Energy Expenditure (EE) in Transsexuals Undergoing Hormonal Therapy
- Conditions
- TransgenderTransgender Persons, M01.777.500
- First Posted Date
- 2024-12-13
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT06733415
- Locations
- 🇮🇱
Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel
© Copyright 2025. All Rights Reserved by MedPath